News from Aratana Therapeutics, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 10, 2017, 11:31 ET Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe

Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced the European...


Nov 02, 2017, 16:05 ET Aratana Therapeutics Reports Third Quarter 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 30, 2017, 08:30 ET Aratana Therapeutics to Present at Credit Suisse Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 13, 2017, 16:05 ET Aratana Therapeutics Announces Launch of ENTYCE® (capromorelin oral solution)

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative pet...


Oct 05, 2017, 16:30 ET Aratana Therapeutics to Report Third Quarter 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Sep 18, 2017, 08:00 ET Aratana Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Aug 03, 2017, 16:30 ET Aratana Therapeutics Reports Second Quarter 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jul 26, 2017, 08:30 ET Aratana Therapeutics Announces Positive Results for AT-003

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Jul 18, 2017, 16:30 ET Aratana Therapeutics to Report Second Quarter 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


May 16, 2017, 08:30 ET Aratana Therapeutics to Participate at Three Upcoming Investment Conferences

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


May 08, 2017, 16:30 ET Aratana Therapeutics Reports First Quarter 2017 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


May 03, 2017, 19:29 ET Aratana Therapeutics Announces Pricing of Registered Direct Offering

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Apr 25, 2017, 16:30 ET Aratana Therapeutics Provides Update on ENTYCE®

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Mar 13, 2017, 16:26 ET Aratana Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Mar 08, 2017, 16:05 ET Aratana Therapeutics to Present at Barclays Capital Global Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Feb 22, 2017, 16:05 ET Aratana Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Feb 03, 2017, 17:10 ET Aratana Therapeutics to Attend North American Veterinary Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Jan 20, 2017, 16:30 ET Aratana Therapeutics Named Animal Pharm's Best Company in North America 2016

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Nov 03, 2016, 17:00 ET Aratana Therapeutics Reports Third Quarter 2016 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 27, 2016, 17:01 ET Aratana Therapeutics to Present at Two Upcoming Investor Conferences

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 19, 2016, 08:30 ET Aratana Therapeutics to Report Third Quarter 2016 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 05, 2016, 08:30 ET Aratana Therapeutics Announces Launch of NOCITA® (bupivacaine liposome injectable suspension)

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Sep 21, 2016, 08:30 ET Aratana Therapeutics to Participate in Jefferies Animal Health Leadership Summit

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Aug 15, 2016, 16:30 ET Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension)

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Aug 04, 2016, 16:20 ET Aratana Therapeutics Reports Second Quarter 2016 Financial Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...